Phase I/II dose-escalation and expansion study of afuresertib + carboplatin and paclitaxel in recurrent ovarian cancer.Sarah P. Blagden, Tarek Meniawy, Anne Hamilton et al.|Journal of Clinical Oncology|2016Cited by 4